EZZ Life Science’s Director Qizhou Qin Increases Shareholding
EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
EZZ Life Science Holdings Ltd. has reported a change in the securities interests of director Qizhou Qin, with the acquisition of 90,830 fully paid ordinary shares through an on-market trade. The transaction, carried out between December 9 and 11, 2024, was priced between $2.52 and $2.71 per share. This adjustment reflects Qin’s continued investment in the company’s growth.
For further insights into AU:EZZ stock, check out TipRanks’ Stock Analysis page.
Trending Articles
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.